Clinical Trial Update: Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing sorafenib with or without gemcitabine and oxaliplatin in locally advanced, unresectable, or metastatic liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED